DK2271340T3 - Farmaceutisk fremstilling omfattende stephaglabrinsulfat til behandling af demyelinisationssygdomme i nervesystemet og til fremmelse af restitution af myelinskeden af nervefibre - Google Patents

Farmaceutisk fremstilling omfattende stephaglabrinsulfat til behandling af demyelinisationssygdomme i nervesystemet og til fremmelse af restitution af myelinskeden af nervefibre

Info

Publication number
DK2271340T3
DK2271340T3 DK08859308.2T DK08859308T DK2271340T3 DK 2271340 T3 DK2271340 T3 DK 2271340T3 DK 08859308 T DK08859308 T DK 08859308T DK 2271340 T3 DK2271340 T3 DK 2271340T3
Authority
DK
Denmark
Prior art keywords
nervous system
stephaglabrine
myeline
sulphate
injury
Prior art date
Application number
DK08859308.2T
Other languages
English (en)
Inventor
Evgeny Veniaminovich Arzamastsev
Klavdia Ignatievna Malinovskaya
Margarita Ivanovna Mironova
Original Assignee
Biogen Technologies Aozt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogen Technologies Aozt filed Critical Biogen Technologies Aozt
Application granted granted Critical
Publication of DK2271340T3 publication Critical patent/DK2271340T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/438—The ring being spiro-condensed with carbocyclic or heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK08859308.2T 2007-12-06 2008-12-05 Farmaceutisk fremstilling omfattende stephaglabrinsulfat til behandling af demyelinisationssygdomme i nervesystemet og til fremmelse af restitution af myelinskeden af nervefibre DK2271340T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
RU2007145037/15A RU2355413C1 (ru) 2007-12-06 2007-12-06 Фармацевтическое средство для лечения демиелинизирующих заболеваний нервной системы, средство, способствующее восстановлению миелиновой оболочки нервного волокна, и способ лечения демиелинизирующих заболеваний нервной системы
PCT/RU2008/000747 WO2009075607A2 (en) 2007-12-06 2008-12-05 Pharmaceutical preparation for treating demyelinating diseases of the nervous system; preparation promoting restoration of the myelin sheath of nerve fibers; and a method for treating demyelinating diseases of the nervous system

Publications (1)

Publication Number Publication Date
DK2271340T3 true DK2271340T3 (da) 2012-06-11

Family

ID=40756011

Family Applications (1)

Application Number Title Priority Date Filing Date
DK08859308.2T DK2271340T3 (da) 2007-12-06 2008-12-05 Farmaceutisk fremstilling omfattende stephaglabrinsulfat til behandling af demyelinisationssygdomme i nervesystemet og til fremmelse af restitution af myelinskeden af nervefibre

Country Status (18)

Country Link
US (2) US8440683B2 (da)
EP (1) EP2271340B1 (da)
JP (1) JP5485166B2 (da)
KR (1) KR20100113505A (da)
CN (1) CN101888842B (da)
AT (1) ATE552001T1 (da)
CA (1) CA2707681C (da)
CY (1) CY1112818T1 (da)
DK (1) DK2271340T3 (da)
EA (1) EA201000786A1 (da)
ES (1) ES2383315T3 (da)
HR (1) HRP20120422T1 (da)
PL (1) PL2271340T3 (da)
PT (1) PT2271340E (da)
RU (1) RU2355413C1 (da)
SI (1) SI2271340T1 (da)
UA (1) UA97875C2 (da)
WO (1) WO2009075607A2 (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102526648B1 (ko) * 2015-08-21 2023-04-27 삼성전자주식회사 2,5-디히드록시벤젠술폰산을 포함하는 신경세포의 수초화를 촉진하기 위한 조성물 및 그의 용도
SG11202006374VA (en) 2018-01-11 2020-07-29 M et P Pharma AG Treatment of demyelinating diseases

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU315388A1 (ru) * 1963-02-04 1977-09-05 Всесоюзный Научно-Исследовательский Институт Лекарственных И Ароматических Растений Лекарственное средство
SU856462A1 (ru) * 1979-07-18 1981-08-23 Одесский Медицинский Институт Им.Н.И.Пирогова Способ лечени больных с двигательными церебральными расстройствами
RU1713151C (ru) * 1986-07-05 1995-02-09 Научно-производственное объединение "ВНИИ лекарственных и ароматических растений" Средство для лечения травматических и послеоперационных повреждений периферической нервной системы
RU2089610C1 (ru) 1994-03-29 1997-09-10 Институт физиологии растений им.К.А.Тимирязева РАН Штамм культивируемых клеток растенийй stephania glabra (roxb) miers - продуцент стефарина
RU2179009C2 (ru) * 1998-02-06 2002-02-10 Предприятие "Васиа" Способ и устройство для реабилитации нервной, мышечной и двигательной координации больных с нарушениями центральной нервной системы
AU2002246619A1 (en) 2000-12-08 2003-06-23 Neuronz Limited Use of insuline-like growth factor-i for promoting remyelination of axons
WO2003041655A2 (en) 2001-11-13 2003-05-22 Loi Tran Therapeutic agent composition and method of use

Also Published As

Publication number Publication date
JP5485166B2 (ja) 2014-05-07
RU2355413C1 (ru) 2009-05-20
WO2009075607A3 (en) 2009-10-29
KR20100113505A (ko) 2010-10-21
US20130226133A1 (en) 2013-08-29
PT2271340E (pt) 2012-06-01
CY1112818T1 (el) 2016-02-10
HRP20120422T1 (hr) 2012-06-30
JP2011506316A (ja) 2011-03-03
SI2271340T1 (sl) 2012-07-31
UA97875C2 (ru) 2012-03-26
ATE552001T1 (de) 2012-04-15
ES2383315T3 (es) 2012-06-20
EA201000786A1 (ru) 2010-12-30
CA2707681A1 (en) 2009-06-18
US8440683B2 (en) 2013-05-14
WO2009075607A2 (en) 2009-06-18
EP2271340A2 (en) 2011-01-12
EP2271340B1 (en) 2012-04-04
PL2271340T3 (pl) 2012-09-28
CN101888842B (zh) 2012-07-04
CN101888842A (zh) 2010-11-17
US20100267756A1 (en) 2010-10-21
CA2707681C (en) 2013-01-08

Similar Documents

Publication Publication Date Title
EA201791669A3 (ru) Новые терапевтические подходы в лечении смт и связанных с ней расстройств
MX2010006519A (es) Metodo para tratar una fractura de hueso con anticuerpos anti-esclerostina.
CO6660423A2 (es) Composiciones y métodos para tratar la enfermedad de gaucher
EA201071245A1 (ru) Новые терапевтические подходы для лечения болезни альцгеймера и связанных нарушений посредством модулирования реакции клеток на стресс
DE602007004514D1 (de) Prä-exzitations-pacing zur behandlung von hypertonie
MX2010004494A (es) Uso de anticuerpos de trkb para el tratamiento de trastornos respiratorios.
JO3267B1 (ar) بيرولات [3، 4-سي] اوكتاهيدروبيرولو ثنائية الاستبدال كمعدلات لمستقبل اوريكسين
EA201590655A8 (ru) Комбинация лахинимода и придопидина для лечения нейродегенеративных нарушений
WO2009038720A3 (en) Method and apparatus for applying light therapy
EA201590654A1 (ru) Комбинация разагилина и придопидина для лечения нейродегенеративных нарушений, в частности болезни хантингтона
UA92636C2 (en) Tetrahydro-pyrimidoazepines as modulators of trpv1
MX2007012847A (es) Antagonistas de npy, preparacion y usos.
BR112012009121A2 (pt) Novas composições para a prevenção e/ou tratamento de distúrbios degenerativos do sistema nervoso central
EP2473037A4 (en) METHOD OF TREATING NEURODEGENERATIVE OR DEGENERATIVE NEUROMUSCULAR DISEASES AND THERAPEUTIC AGENT FOR TREATING THESE DISEASES
MX2009013205A (es) Derivados de pirazoloquinolina urea terapeuticos.
TW200733976A (en) Method for the treatment of cognitive dysfunction
MX2009013197A (es) Derivados terapeuticos de pirazolonaftiridina.
EA200970436A1 (ru) Соединения карбамата для лечения депрессии
MX381106B (es) Metodo de tratamiento de la enfermedad por anestesia auricular de los nervios craneales.
MX2009013202A (es) Derivados terapeuticos de pirazoloquinolina.
DK2020999T3 (da) Sammensætninger omfattende alfa-ketoglutarat og deres anvendelse til modulering af muskelperformance
ATE552001T1 (de) Stephaglabrinsulfat umfassende pharmazeutische zubereitung zur behandlung von demyelinierenden erkrankungen des nervensystems und zur förderung der wiederherstellung der myelinscheide von nervenfasern
EP2566856A4 (en) COMPOUNDS AND METHOD FOR TREATING BRAIN DISEASES
DK1732551T3 (da) Perhexilin til behandling af kronisk hjertesvigt
ATE502637T1 (de) Medikamente zur prävention oder behandlung von herzversagen mit einem anticholinergikum